Analysis of AR/ARV7 Expression in Isolated Circulating Tumor Cells of Patients with Metastatic Castration-Resistant Prostate Cancer (SAKK 08/14 IMPROVE Trial)

Despite several treatment options and an initial high response rate to androgen deprivation therapy, the majority of prostate cancers will eventually become castration-resistant in the metastatic stage (mCRPC). Androgen receptor splice variant 7 (ARV7) is one of the best-characterized androgen recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Bratic Hench, Ivana, Cathomas, Richard, Costa, Luigi, Fischer, Natalie, Gillessen, Silke, Hench, Jürgen, Hermanns, Thomas, Kremer, Eloïse, Mingrone, Walter, Pereira Mestre, Ricardo, Püschel, Heike, Rothermundt, Christian, Ruiz, Christian, Tolnay, Markus, Von Burg, Philippe, Bubendorf, Lukas, Vlajnic, Tatjana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721786/
https://www.ncbi.nlm.nih.gov/pubmed/31374981
http://dx.doi.org/10.3390/cancers11081099

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721786/
https://www.ncbi.nlm.nih.gov/pubmed/31374981
http://dx.doi.org/10.3390/cancers11081099

Ejemplares similares